Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$657M |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Amazon
AMZN
|
+$587M |
| 4 |
AstraZeneca
AZN
|
+$319M |
| 5 |
Snowflake
SNOW
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$323M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$273M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$121M |
| 4 |
PFPT
Proofpoint, Inc.
PFPT
|
+$98.6M |
| 5 |
JD.com
JD
|
+$89.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.03% |
| 2 | Financials | 13.72% |
| 3 | Healthcare | 12.6% |
| 4 | Consumer Discretionary | 10.97% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
Ocugen
OCGN
$434M
| $592K | ﹤0.01% |
82,408
+38,672
| +88% | +$284K |
|
|
STFC
2377
DELISTED
State Auto Financial Corp
STFC
| $587K | ﹤0.01% |
11,536
+3,935
| +52% | +$186K |
|
2378
Zentalis Pharmaceuticals
ZNTL
$302M
| $585K | ﹤0.01% |
8,788
+4,242
| +93% | +$245K |
|
2379
BellRing Brands
BRBR
$1.34B
| $581K | ﹤0.01% |
18,908
+7,469
| +65% | +$239K |
|
2380
The RealReal
REAL
$1.5B
| $580K | ﹤0.01% |
44,004
+23,807
| +118% | +$353K |
|
|
CRON
2381
Cronos Group
CRON
$1.14B
| $577K | ﹤0.01% |
102,233
+18,256
| +22% | +$124K |
|
2382
Globalstar
GSAT
$10.8B
| $575K | ﹤0.01% |
22,917
+16,449
| +254% | +$403K |
|
2383
PLDT
PHI
$4.33B
| $573K | ﹤0.01% |
17,615
| – | – |
|
|
INFN
2384
DELISTED
Infinera Corporation Common Stock
INFN
| $565K | ﹤0.01% |
67,862
+33,961
| +100% | +$308K |
|
2385
Rush Street Interactive
RSI
$2.88B
| $560K | ﹤0.01% |
29,144
+10,441
| +56% | +$143K |
|
2386
Matrix Service
MTRX
$335M
| $559K | ﹤0.01% |
53,466
+394
| +0.7% | +$4.22K |
|
|
EB
2387
DELISTED
Eventbrite
EB
| $558K | ﹤0.01% |
29,508
+13,670
| +86% | +$240K |
|
2388
Suzano
SUZ
$10.1B
| $551K | ﹤0.01% |
55,121
| – | – |
|
2389
Alphatec Holdings
ATEC
$1.44B
| $548K | ﹤0.01% |
44,959
+12,402
| +38% | +$173K |
|
|
PFC
2390
DELISTED
Premier Financial Corp. Common Stock
PFC
| $544K | ﹤0.01% |
17,098
+7,371
| +76% | +$213K |
|
2391
Amneal Pharmaceuticals
AMRX
$5.79B
| $543K | ﹤0.01% |
101,633
+18,694
| +23% | +$94.1K |
|
2392
Community Trust Bancorp
CTBI
$1.41B
| $543K | ﹤0.01% |
12,896
+3,019
| +31% | +$122K |
|
2393
MakeMyTrip
MMYT
$5.64B
| $539K | ﹤0.01% |
19,817
| – | – |
|
2394
Anavex Life Sciences
AVXL
$310M
| $538K | ﹤0.01% |
30,006
+19,940
| +198% | +$397K |
|
2395
Park Aerospace
PKE
$819M
| $532K | ﹤0.01% |
38,897
+1,306
| +3% | +$19.2K |
|
2396
Gevo
GEVO
$382M
| $529K | ﹤0.01% |
79,702
+39,142
| +97% | +$242K |
|
|
RAD
2397
DELISTED
Rite Aid Corporation
RAD
| $521K | ﹤0.01% |
36,705
-76,593
| -68% | -$1.21M |
|
2398
Northern Oil and Gas
NOG
$2.35B
| $518K | ﹤0.01% |
24,212
+11,301
| +88% | +$197K |
|
2399
PAR Technology
PAR
$735M
| $518K | ﹤0.01% |
8,432
+4,880
| +137% | +$313K |
|
2400
Travere Therapeutics
TVTX
$5.78B
| $515K | ﹤0.01% |
21,238
+10,816
| +104% | +$199K |
|
Similar funds
Legal & General Group's Q3 2021 Portfolio in Review
As of Q3 2021, Legal & General Group held 3,551 positions worth $308B, up 2.9% from $299B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Legal & General Group deployed $10.7B of net new capital in Q3 2021, opening 77 new positions and adding to 2,293 existing holdings. Its largest new stake was AstraZeneca: 2,738,007 shares worth $329M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was JD.com, an estimated $89.3M trimmed.
- Legal & General Group's largest Q3 2021 buy was AstraZeneca: 2,738,007 shares worth $329M.
- Legal & General Group added most to Microsoft in Q3 2021, an estimated $657M increase.
- Legal & General Group's biggest Q3 2021 reduction was JD.com, cutting an estimated $89.3M.
- Legal & General Group fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $323M.
- Legal & General Group's ten largest holdings make up 22% of its $308B portfolio in Q3 2021.
- Legal & General Group opened 77 new positions and closed 55 in Q3 2021.
- Legal & General Group's portfolio value rose 2.9% quarter-over-quarter to $308B.
Based on Legal & General Group's 13F filing for Q3 2021, filed 15 Nov 2021.